Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.55 USD | +5.21% | +21.48% | +4.15% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.15% | 1.67B | |
+73.17% | 12.38B | |
-15.87% | 8.2B | |
+17.74% | 7.3B | |
+10.58% | 5.32B | |
+33.33% | 4.78B | |
-18.88% | 4.16B | |
-35.55% | 2.43B | |
+0.99% | 2.05B | |
+9.66% | 1.98B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wells Fargo Adjusts Price Target on NovoCure to $74 From $70, Keeps Equal Weight Rating